WAFB Channel 9, Baton Rouge, LA |Pfizer gets FDA approval for intravenous Revatio
Member Center:
 |
 |
NEW YORK (AP) - Drug developer Pfizer Inc. said Friday the Food and Drug Administration approved an intravenous version of its high blood pressure drug Revatio.
The drug was already sold as a tablet. It is used as a treatment for adults with pulmonary arterial hypertension, which affects about 100,000 people worldwide.
Shares of Pfizer rose 14 cents to $18.25 inmorning trading.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
